Editorial 2: ​India needs research pipelines

Context

The economies that turned science into industry shared a simple discipline: they linked company outlays to university strengths and kept that partnership stable for years.

Introduction

India cannot meet its growth ambitions on public grants alone. The countries that successfully converted science into industry did one thing consistently: they aligned firm investments with university strengths and sustained that partnership over many years. This frames a clear policy challenge for India—how to shift private research spending from episodic CSR gestures to a predictable innovation pipeline that purchases real lab time, supports doctoral cohorts, and secures pilot production lines. Only then can research funding translate into scalable industrial outcomes.

Global Models of Corporate–Campus Research

• Industrial-scale innovation budgets: Leading tech firms invest at levels that rival national R&D spending. In 2024, Meta allocated about $44 billion, nearly one-third of its revenue. Alphabet, Amazon, Apple, IBM, and Microsoft also maintained multibillion-dollar research programmes.
• High enterprise research intensity: U.S. companies booked roughly $692 billion of domestic R&D against $14 trillion in net sales in 2022—an R&D-to-sales ratio near 5%.
• Policy instruments that convert funding into partnerships: The NSF’s Industry–University Cooperative Research Centers pool company contributions for pre-competitive university research, while the Semiconductor Research Corporation supports multi-university consortia that train talent and solve industry-aligned problems.
• China’s high-intensity R&D models: Huawei reported 179.7 billion yuan in R&D in 2024 (about 20.8% of revenue), with over half its workforce in R&D. BYD invested 54.2 billion yuan against 777 billion yuan of revenue, an R&D intensity of nearly 7%.
• Shared traits: Corporate research works through joint centres, shared lines, long-horizon consortia, and open talent pathways—a model India must scale on Indian terms.

India’s Position and Pathways for Scale

• Current national baseline: India’s GERD stands near 0.65% of GDP, with enterprises contributing around two-fifths—lower than advanced economies where the firm share is much higher.
• Emerging Indian leaders:
  • Tata Motors invested ₹29,398 crore in FY24, an R&D intensity of 6.7%.
  • Sun Pharma spent 6.7% of global revenue on R&D in FY24.
  • Dr. Reddy’s invested ₹22.9 billion, about 8.2% of sales.
  • Bharat Electronics dedicated 6.24% of turnover to R&D, signalling strength in a strategic sector.
  • Reliance Industries recorded over ₹4,100 crore of R&D expenditure in FY2024-25.
• Strengthening partnerships: India already operates effective models—
  • IIT Madras Research Park, hosting 200+ companies adjacent to labs and student teams.
  • iDEX, which enables defence innovation by linking startups and research labs.
  • India Semiconductor Mission, which ties industry investments, skill pipelines, and academic partners, exemplified by the Micron ATMP project in Sanand.
• Strategic goal: Build self-reliance with global openness, anchoring discovery to India’s needs. This requires scale, predictability, and structured linkages between private R&D and HEIs, turning research into a stable national engine rather than episodic CSR.

Scaling India’s Research–Industry Linkages

• Set sector-wise R&D expectations: Establish three-year R&D-to-sales ratios for automobiles, pharma, electronics, defence, space, and energy, rising gradually while respecting export targets and cash-flow constraints. Adopt shared IP frameworks that reward both publication and commercialisation.
• Strengthen co-funded research models: Incentivise co-funded projects, shared facilities, and matching grantsrouted through HEIs for multi-year work with open data, clear deliverables, and industry-relevant KPIs. Introduce a dedicated line item for university-run pilot lines and testbeds that companies can book by the hour. Build multi-university centres around problem portfolios rather than single projects.
• Modernise tax tools for R&D: Direct weighted deductions toward measurable outputs—patents, standards, clinical milestones, field trials. Tie incentives to collaboration with accredited HEIs and to hiring graduate researchers into industry.
• Build collaboration capabilities: Support campus programmes that train faculty and PhD scholars in working with industry, negotiating IP, and running translational projects. Expand pathways for PhDs in product teams, create dual-track roles with adjunct appointments, and sponsor doctoral cohorts aligned to company roadmaps.
• Improve corporate disclosure: Encourage listed firms to report R&D spending and the share directed to Indian HEIs. Better disclosure nudges boards to treat R&D as strategic. Publish results in Indian languages and practitioner-friendly formats to build prestige around research careers.

Anchoring Innovation in India’s Knowledge Ecosystem

• India’s campuses sit beside dynamic markets and draw on deep knowledge traditions that situate technology within broader human inquiry.
• When corporate research engages this heritage, it acquires context, depth, and relevance, strengthening the very capabilities required for high-performing industrial R&D.

Conclusion 

India already possesses the labs, talent, and markets needed for world-class innovation. What the industry must now do is set transparent targets, provide grants that fund real lab time, and build stronger collaborative networks. Academic institutions, on their part, should focus on research with measurable value, remain open to industry-driven questions, and consistently demonstrate evidence of outcomes. When both sides align in this way, research evolves into a national supply chain for innovation rather than a matter of wishful thinking.